🇨🇦 Ly-Cov016 in Canada

Ly-Cov016 (ETESEVIMAB) regulatory status in Canada.

Marketing authorisation

Ly-Cov016 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in Canada

Frequently asked questions

Is Ly-Cov016 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Ly-Cov016 in Canada?

Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.